About
Science
- PAM Pathway
- Publications
Pipeline
Clinical Trials
Investors
Careers

Phase 1/2 Study of Gedatolisib in Combination with Darolutamide in Metastatic Castration-Resistant Prostate Cancer

Post navigation

Gedatolisib Plus Fulvestrant, With & Without Palbociclib, vs Fulvestrant in Patients With HR+/HER2-/PIK3CA Wild-Type Advanced Breast Cancer: First Results from VIKTORIA-1

Search for:

Recent Posts

Developing first-in-class therapeutics using a 3rd generation diagnostic platform

Recent Comments

Archives

October 2021

Categories

Uncategorized

Meta

Log in
Entries feed
Comments feed
WordPress.org

16305 36th Avenue North
Minneapolis, MN 55446

Follow us on

in x

©2025 Celcuity Inc.

Privacy Policy Accessibility Statement